Trial Profile
Efficacy and safety of fixed dose combination of Indapamide/Amlodipin in patients with high risk factors for coronary artery diseases and severe hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2016
Price :
$35
*
At a glance
- Drugs Indapamide/amlodipine (Primary)
- Indications Essential hypertension; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 23 Dec 2016 New trial record